C2 Blockchain Secures Highly Dilutive Capital via Toxic Debt and Deep Discount Equity Sales
summarizeSummary
C2 Blockchain raised $138,000 through a highly dilutive convertible note and deeply discounted equity sales, providing critical liquidity but at terms that will significantly dilute existing shareholders.
check_boxKey Events
-
Convertible Promissory Note Issued
On April 23, 2026, C2 Blockchain issued a convertible promissory note to Labrys Fund II, L.P. with a principal amount of $120,000, receiving gross proceeds of $100,000 after a $20,000 original issue discount.
-
Highly Dilutive Conversion Terms
The note converts at 75% of the lowest closing bid price during the ten trading days immediately preceding the conversion date, and includes a clause to adjust the conversion price lower if the company issues other securities at a lower effective price.
-
Deeply Discounted Equity Sales
The company sold 3,000,000 shares on April 28, 2026, and 800,000 shares on April 30, 2026, to accredited investors at a purchase price of $0.01 per share, raising aggregate gross proceeds of $38,000.
-
Addressing Going Concern
This capital raise provides immediate liquidity for the company, which previously disclosed substantial doubt about its ability to continue as a going concern in its last 10-Q filing.
auto_awesomeAnalysis
C2 Blockchain has raised $138,000 in gross proceeds through a convertible promissory note and direct equity sales. While this capital infusion is critical for a company that previously disclosed substantial doubt about its ability to continue as a going concern, the terms of the financing are highly unfavorable and significantly dilutive for existing shareholders. The convertible note features a 'death spiral' conversion mechanism, allowing the holder to convert at a deep discount to future market prices (75% of the lowest bid in 10 days), and includes strong anti-dilution protections for the noteholder. The direct equity sales were also executed at a substantial discount to the current market price ($0.01 per share vs. current $0.065). This financing structure suggests a desperate need for capital, and the terms will likely lead to significant future dilution, further eroding shareholder value. This comes amidst recent news of the company increasing its holdings in volatile crypto assets, raising questions about capital allocation given the dilutive financing.
At the time of this filing, CBLO was trading at $0.07 on OTC in the Crypto Assets sector, with a market capitalization of approximately $29.6M. The 52-week trading range was $0.01 to $0.30. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.